Reported about 18 hours ago
Pfizer Inc. has successfully finalized its exit from Haleon Plc by raising approximately $3.3 billion through the sale of its remaining 7.3% stake. This sale, encompassing about 618 million shares, follows a series of divestments that started years ago after Haleon's formation from the merger of GSK and Pfizer's consumer health units. Despite reported strong quarterly results for Haleon, Pfizer has been steadily reducing its investment in the company.
Source: YAHOO